Suppr超能文献

使用实时 PCR 的基因表达研究确定 NTR 基因是对抗 Benzonidazole 在 Trypanosoma cruzi 中的抗性的主要标志物。

Gene expression study using real-time PCR identifies an NTR gene as a major marker of resistance to benzonidazole in Trypanosoma cruzi.

机构信息

Grupo Biología y Control de Enfermedades Infecciosas-BCEI-SIU, Instituto de Biología, Universidad de Antioquia, Medellín, Colombia.

出版信息

Parasit Vectors. 2011 Sep 5;4:169. doi: 10.1186/1756-3305-4-169.

Abstract

BACKGROUND

Chagas disease is a neglected illness, with limited treatments, caused by the parasite Trypanosoma cruzi. Two drugs are prescribed to treat the disease, nifurtimox and benznidazole, which have been previously reported to have limited efficacy and the appearance of resistance by T. cruzi. Acquisition of drug-resistant phenotypes is a complex physiological process based on single or multiple changes of the genes involved, probably in its mechanisms of action.

RESULTS

The differential genes expression of a sensitive Trypanosoma cruzi strain and its induced in vitro benznidazole-resistant phenotypes was studied. The stepwise increasing concentration of BZ in the parental strain generated five different resistant populations assessed by the IC(50) ranging from 10.49 to 93.7 μM. The resistant populations maintained their phenotype when the BZ was depleted from the culture for many passages. Additionally, the benznidazole-resistant phenotypes presented a cross-resistance to nifurtimox but not to G418 sulfate. On the other hand, four of the five phenotypes resistant to different concentrations of drugs had different expression levels for the 12 genes evaluated by real-time PCR. However, in the most resistant phenotype (TcR5x), the levels of mRNA from these 12 genes and seven more were similar to the parental strain but not for NTR and OYE genes, which were down-regulated and over-expressed, respectively. The number of copies for these two genes was evaluated for the parental strain and the TcR5x phenotype, revealing that the NTR gene had lost a copy in this last phenotype. No changes were found in the enzyme activity of CPR and SOD in the most resistant population. Finally, there was no variability of genetic profiles among all the parasite populations evaluated by performing low-stringency single-specific primer PCR (LSSP-PCR) and random amplified polymorphic DNA RAPD techniques, indicating that no clonal selection or drastic genetic changes had occurred for the exposure to BZ.

CONCLUSION

Here, we propose NTR as the major marker of the appearance of resistance to BZ.

摘要

背景

恰加斯病是一种被忽视的疾病,由寄生虫克氏锥虫引起,目前的治疗方法有限。目前有两种药物被用于治疗该病,分别是硝呋替莫和苯唑硝唑,但此前有报道称这两种药物的疗效有限,而且克氏锥虫已经出现了耐药性。获得耐药表型是一个复杂的生理过程,涉及到相关基因的单一或多种变化,这些变化可能与其作用机制有关。

结果

本研究对敏感型克氏锥虫株及其体外诱导的苯唑硝唑耐药表型的差异基因表达进行了研究。在亲代菌株中,苯唑硝唑的浓度逐渐增加,生成了五个不同的耐药群体,其 IC₅₀值范围为 10.49 至 93.7 μM。当 BZ 从培养物中耗尽时,耐药群体在许多传代中仍能保持其表型。此外,苯唑硝唑耐药表型对硝呋替莫具有交叉耐药性,但对硫酸新霉素不耐药。另一方面,在对不同药物浓度耐药的五种表型中,有 12 个基因的实时 PCR 评估显示出不同的表达水平。然而,在最耐药的表型(TcR5x)中,这 12 个基因和另外 7 个基因的 mRNA 水平与亲代菌株相似,但 NTR 和 OYE 基因则下调和过表达。这两个基因的拷贝数在亲代菌株和 TcR5x 表型中进行了评估,结果表明 NTR 基因在最后一个表型中丢失了一个拷贝。在最耐药的群体中,CPR 和 SOD 的酶活性没有变化。最后,通过进行低严格性单特异性引物 PCR(LSSP-PCR)和随机扩增多态性 DNA RAPD 技术,对所有评估的寄生虫群体的遗传谱进行了分析,结果表明在接触苯唑硝唑后没有发生克隆选择或遗传剧变。

结论

本研究提出 NTR 是苯唑硝唑耐药出现的主要标记。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aade/3185274/4843779752bc/1756-3305-4-169-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验